Pharmacokinetic-Based Drug–Drug Interactions with Anaplastic Lymphoma Kinase Inhibitors: A Review

Anaplastic lymphoma kinase (ALK) inhibitors are important treatment options for non-small-cell lung cancer (NSCLC), associated with ALK gene rearrangement. Patients with ALK gene rearrangement show sensitivity to and benefit clinically from treatment with ALK tyrosine kinase inhibitors (ALK-TKIs). T...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Dehua, Chen, Jing, Chu, Mingming, Long, Xiaoqing, Wang, Jisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198400/
https://www.ncbi.nlm.nih.gov/pubmed/32431491
http://dx.doi.org/10.2147/DDDT.S249098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198400/
https://www.ncbi.nlm.nih.gov/pubmed/32431491
http://dx.doi.org/10.2147/DDDT.S249098

Ejemplares similares